Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients.

Jing ZhangWen-Xian LiuShu-Zheng Lyu

Published in: Cardiovascular therapeutics (2020)

We demonstrated that an elevated EMATc measured at admission is an independent risk factor for MACEs among hospitalized CHF patients. Acoustic cardiography measured at admission may provide a simple, noninvasive method for risk stratification of CHF patients. This trial is registered with ChiCTR1900021470.

Keyphrases

ejection fraction
end stage renal disease
emergency department
prognostic factors
healthcare
clinical trial
randomized controlled trial
heart failure
patient reported outcomes
electronic health record
atrial fibrillation
phase ii
open label
adverse drug
acute care
placebo controlled